Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
APEI
|
Richard W Sunderland Jr
EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,032 Reduced 0.97% |
$20,413
$19.78 p/Share
|
Feb 25
2022 |
|
APEI
|
Richard W Sunderland Jr
EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 10,280 Added 8.84% |
-
|
Feb 25
2022 |
|
APEI
|
Angela K. Selden
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 4,537 Reduced 2.03% |
$89,742
$19.78 p/Share
|
Feb 25
2022 |
|
APEI
|
Angela K. Selden
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 34,580 Added 13.43% |
-
|
Feb 25
2022 |
|
SSTI
|
Paul S. Ames
SVP Products and Technology |
SELL
Open market or private sale
|
Direct | 1,062 Reduced 1.59% |
$26,253
$24.72 p/Share
|
Feb 25
2022 |
|
SSTI
|
Gary T Bunyard
Sr. VP Public Safety Solutions |
SELL
Open market or private sale
|
Direct | 393 Reduced 1.53% |
$9,652
$24.56 p/Share
|
Feb 25
2022 |
|
NCV
|
Philip R Mc Loughlin
Director |
BUY
Open market or private purchase
|
Direct | 2,100 Added 50.0% |
$10,395
$4.95 p/Share
|
Feb 25
2022 |
|
TUP
|
Calero Miguel Angel Fernandez
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 55,013 Added 10.38% |
-
|
Feb 25
2022 |
|
TUP
|
Cassandra Harris
CFO & COO |
BUY
Grant, award, or other acquisition
|
Direct | 17,192 Added 13.8% |
-
|
Feb 25
2022 |
|
TUP
|
Patricio Cuesta
President, Commercial WW |
BUY
Grant, award, or other acquisition
|
Direct | 9,169 Added 5.52% |
-
|
Feb 25
2022 |
|
TUP
|
Hector Lezama
Chief Commercial Officer (CCO) |
BUY
Grant, award, or other acquisition
|
Direct | 9,169 Added 5.23% |
-
|
Feb 25
2022 |
|
TUP
|
Karen M Sheehan
EVP, CLO & Secretary |
BUY
Grant, award, or other acquisition
|
Direct | 8,405 Added 11.61% |
-
|
Feb 25
2022 |
|
TUP
|
Madeline Otero
SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 3,821 Added 15.38% |
-
|
Feb 25
2022 |
|
TUP
|
Richard Goudis
Executive Vice Chair |
BUY
Grant, award, or other acquisition
|
Direct | 6,113 Added 10.15% |
-
|
Feb 25
2022 |
|
BLFY
|
Brent Michael Ciurlino
EVP and CRO |
BUY
Open market or private purchase
|
Direct | 1,000 Added 10.0% |
$13,590
$13.59 p/Share
|
Feb 25
2022 |
|
CVEO
|
Barclay Brewer
Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct | 3,200 Reduced 30.26% |
$70,304
$21.97 p/Share
|
Feb 25
2022 |
|
CVEO
|
Barclay Brewer
Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 3,200 Added 23.23% |
-
|
Feb 25
2022 |
|
CVEO
|
Barclay Brewer
Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 316 Reduced 4.28% |
$6,943
$21.97 p/Share
|
Feb 25
2022 |
|
CVEO
|
Bradley J Dodson
President & CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct | 39,310 Reduced 19.66% |
$863,641
$21.97 p/Share
|
Feb 25
2022 |
|
CVEO
|
Bradley J Dodson
President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 39,310 Added 16.43% |
-
|
Feb 25
2022 |
|
CVEO
|
Carolyn J Stone
SVP, CFO & Treasurer |
SELL
Sale (or disposition) back to the issuer
|
Direct | 7,672 Reduced 20.79% |
$168,554
$21.97 p/Share
|
Feb 25
2022 |
|
CVEO
|
Carolyn J Stone
SVP, CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct | 7,672 Added 17.21% |
-
|
Feb 25
2022 |
|
CVEO
|
Allan Schoening
SVP, Canada |
SELL
Sale (or disposition) back to the issuer
|
Direct | 8,598 Reduced 28.46% |
$188,898
$21.97 p/Share
|
Feb 25
2022 |
|
CVEO
|
Allan Schoening
SVP, Canada |
BUY
Exercise of conversion of derivative security
|
Direct | 8,598 Added 22.16% |
-
|
Feb 25
2022 |
|
CVEO
|
Peter Mc Cann
SVP, Australia |
SELL
Sale (or disposition) back to the issuer
|
Direct | 5,809 Reduced 13.08% |
$127,624
$21.97 p/Share
|
Feb 25
2022 |
|
CVEO
|
Peter Mc Cann
SVP, Australia |
BUY
Exercise of conversion of derivative security
|
Direct | 5,809 Added 11.57% |
-
|
Feb 25
2022 |
|
FUBO
|
John Janedis
Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 3,000 Added 50.0% |
$24,120
$8.04 p/Share
|
Feb 25
2022 |
|
MDXG
|
Peter M Carlson
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 17,400 Reduced 4.24% |
$84,042
$4.83 p/Share
|
Feb 25
2022 |
|
HAYN
|
Gregory W. Tipton
VP AND CIO |
SELL
Payment of exercise price or tax liability
|
Direct | 419 Reduced 4.86% |
$15,725
$37.53 p/Share
|
Feb 25
2022 |
|
WKHS
|
Anthony Daly Furey
Vice President-Finance |
SELL
Payment of exercise price or tax liability
|
Direct | 1,773 Reduced 0.8% |
$5,390
$3.04 p/Share
|
Feb 25
2022 |
|
WKHS
|
Gregory T. Ackerson
Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,128 Reduced 0.63% |
$3,429
$3.04 p/Share
|
Feb 25
2022 |
|
SMBC
|
Daniel Lee Jones |
BUY
Grant, award, or other acquisition
|
Indirect | 271,929 Added 50.0% |
-
|
Feb 25
2022 |
|
MPB
|
Theodore W Mowery
Director |
BUY
Open market or private purchase
|
Indirect | 50 Added 0.64% |
$1,455
$29.09 p/Share
|
Feb 25
2022 |
|
MPB
|
Theodore W Mowery
Director |
BUY
Open market or private purchase
|
Direct | 150 Added 0.78% |
$4,331
$28.87 p/Share
|
Feb 25
2022 |
|
CARA
|
Joana Goncalves
CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct | 1,972 Reduced 2.51% |
$20,292
$10.29 p/Share
|
Feb 25
2022 |
|
CARA
|
Joana Goncalves
CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 20,000 Added 20.3% |
-
|
Feb 25
2022 |
|
CARA
|
Frederique Ph.D. Menzaghi
CHIEF SCIENTIFIC OFF,SVP-R&D |
SELL
Open market or private sale
|
Direct | 2,114 Reduced 1.22% |
$21,753
$10.29 p/Share
|
Feb 25
2022 |
|
CARA
|
Frederique Ph.D. Menzaghi
CHIEF SCIENTIFIC OFF,SVP-R&D |
BUY
Grant, award, or other acquisition
|
Direct | 20,000 Added 10.33% |
-
|
Feb 25
2022 |
|
CARA
|
Christopher Posner
PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct | 39,000 Added 16.11% |
-
|
Feb 25
2022 |
|
CARA
|
Thomas Charles Reilly
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 20,000 Added 36.68% |
-
|
Feb 25
2022 |
|
CARA
|
Scott Terrillion
SEC'Y; CHIEF COMPLIANCE & G.C. |
SELL
Open market or private sale
|
Direct | 1,972 Reduced 1.93% |
$20,292
$10.29 p/Share
|
Feb 25
2022 |
|
CARA
|
Scott Terrillion
SEC'Y; CHIEF COMPLIANCE & G.C. |
BUY
Grant, award, or other acquisition
|
Direct | 20,000 Added 16.34% |
-
|
Feb 25
2022 |
|
AAN
|
Rachel G George
EVP, Gen Counsel/Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct | 34,809 Added 45.26% |
$746,653
$21.45 p/Share
|
Feb 25
2022 |
|
AAN
|
Douglass L Noe
VP, Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct | 9,852 Added 41.69% |
$211,325
$21.45 p/Share
|
Feb 25
2022 |
|
AAN
|
Christopher K Wall
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 38,361 Added 35.89% |
$822,843
$21.45 p/Share
|
Feb 25
2022 |
|
AAN
|
Stephen W Olsen
President |
BUY
Grant, award, or other acquisition
|
Direct | 52,590 Added 31.66% |
$1,128,056
$21.45 p/Share
|
Feb 25
2022 |
|
AAN
|
Douglas A Lindsay
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 197,466 Added 33.44% |
$4,235,646
$21.45 p/Share
|
Feb 25
2022 |
|
MCS
|
Thomas F Kissinger
Sr Exec VP, Gen Counsel & Secy |
SELL
Payment of exercise price or tax liability
|
Direct | 2,165 Reduced 1.96% |
$39,143
$18.08 p/Share
|
Feb 25
2022 |
|
MCS
|
Gregory S Marcus
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 7,645 Reduced 4.77% |
$138,222
$18.08 p/Share
|
Feb 25
2022 |
|
MCS
|
Douglas A Neis
CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,027 Reduced 4.04% |
$36,648
$18.08 p/Share
|
Feb 25
2022 |